Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use

Table 1 Characteristics of the patients in NICU with RSV positive test

	GA (weeks)	Birth weight (grams)	Age (days) at RSV diagnose	Time of viral excretion	Underlying condition	Respiratory symptoms	Symptoms
Index case	27	965 g	79	2 weeks	PDA/BPD	Yes - MV due to RSV infection	Yes
1	27	830 g	65	Negative control*	Hydrocelle/GI Malformation	YES – MV due to RSV infection	Yes
2	27	585 g	46	3 weeks	RDS/PDA/inguinal hernia	MV - Worsening of parameters	Yes
3	26	560 g	80	5 weeks	RDS/PDA/BPD	MV – worsening of parameters	Yes
4	33	1720 g	97	Negative control*	Onphalocele/PDA/PH/BPD	n-CPAP due to RSV	Yes
5	25	795 g	51	3 weeks	RDS/PDA/ARF	MV–worsening of parameter s	Yes
6	34	2575 g	38	3 weeks	RDS	Previous in MV	No
7	25	715 g	26	2 weeks	RDS/PDA	Previous in MV	No
8	25	650 g	26	2 weeks	RDS/PDA/BPD	MV – worsening of parameter s	Yes
9	27	1230 g	32	Negative control*	RDS/PDA	No – No 02 Support	No
10	32	2150 g	37	2 weeks	RDS	No – No 02 support	No

GA = Gestational Age; PDA = patent ductus arteriosus; BD = Bronchopulmonary dysplasia; RDS = Respiratory distress syndrome; GI = Gastrointestinal; PH = Pulmonary hypertension; ARF = acute renal failure; MV = Mechanical ventilation; n-CPAP: nasal continuous positive airway pressure.
*Negative Control – negative test on the 14th day after diagnostic.

ISSN: 2047-2994